diclofenac
1. Basic Product Identification
INN Name: Diclofenac
Therapeutic Class: NSAID (Non-copyrightal Anti-Inflammatory Drug)
Common Salts: Diclofenac sodium, Diclofenac potassium
Dosage Forms:
Tablets (IR / SR)
Injectable solution
Topical gels / creams
Suppositories
Key Indications:
Pain & inflammation
Arthritis
Musculoskeletal disorders
Post-operative pain
Migraine (potassium salt fast acting)
2. Therapeutic Knowledge
Diclofenac is widely used for:
Osteoarthritis
Rheumatoid arthritis
Ankylosing spondylitis
Acute musculoskeletal pain
Post-surgical inflammation
Dysmenorrhea
Migraine (acute attack)
3. Mechanism of Action (MOA)
Diclofenac inhibits cyclooxygenase enzymes (COX-1 & COX-2).
Pathway:
↓ COX enzyme activity
↓ prostaglandin synthesis
Effects:
Anti-inflammatory
Analgesic (pain relief)
Antipyretic (fever reduction)
???? COX-2 preference slightly higher than older NSAIDs, but still non-selective.
4. Pharmacokinetics (ADME)
Absorption
Oral bioavailability: ~50–60%
Rapid absorption (especially potassium salt)
Distribution
~99% protein bound (albumin)
Metabolism
Hepatic (CYP2C9 major pathway)
Excretion
Urine (~65%)
Bile/feces (~35%)
Half-life:
1–2 hours (short), but duration extended due to tissue binding
5. Dosage & Administration
Oral:
50 mg 2–3 times daily
SR formulations: 75–100 mg once or twice daily
Injectable:
75 mg IM deep injection
Topical:
1% or 2% gel applied 2–4 times daily
Administration notes:
Take with food to reduce GI irritation
Use lowest effective dose for shortest duration
6. Formulation Knowledge
Oral tablets:
IR / enteric-coated / SR forms
Injectable:
Aqueous solution (often pH-adjusted with buffers)
Topical gels:
Carbomer-based gel systems
Alcohol + penetration enhancers
Key formulation challenges:
Poor water solubility
GI irritation (oral)
Stability in aqueous injectable forms
7. Raw Materials Knowledge
API:
Diclofenac sodium or potassium salt
Excipients:
Microcrystalline cellulose
Lactose / starch
Povidone (binder)
Magnesium stearate
Gel-forming polymers (topical)
Critical raw material concern:
Purity of intermediates (phenylacetic acid derivatives)
Control of impurities (chloroaniline-related)
8. Manufacturing Process Knowledge
API synthesis:
Multi-step organic synthesis:
Phenylacetic acid derivative formation
Chlorination + coupling reactions
Purification via crystallization
Tablet manufacturing:
Granulation (wet or dry)
Compression
Coating (enteric/SR if needed)
Gel manufacturing:
Polymer dispersion
API solubilization
Homogenization
Injectable:
Sterile solution preparation
Filtration (0.22 µm)
Aseptic filling
9. Analytical & QC Knowledge
Key tests:
HPLC assay
Related substances
Dissolution testing
Content uniformity
pH (injectable/topical)
Viscosity (gel)
Stability methods:
Photodegradation studies
Hydrolysis under pH stress
Thermal degradation profiling
10. Regulatory Knowledge
Status:
WHO essential medicine
Globally approved NSAID
Regulatory requirements:
Bioequivalence (oral forms)
Sterile validation (injectables)
Topical dermal absorption studies (gel products)
Label requirements:
GI bleeding risk
Cardiovascular risk warning
Long-term use caution
11. Storage & Stability
Store at 15–25°C
Protect from moisture & light
Stability risks:
Hydrolysis (especially injectable forms)
Photodegradation
Gel viscosity breakdown over time
12. Packaging Knowledge
Oral:
Alu-Alu blister (moisture protection)
Injectable:
Glass ampoules / vials
Topical:
Laminated aluminum tubes
Airless pump containers (premium)
13. Safety & Toxicology
Common side effects:
Gastric irritation
Nausea
Headache
Dizziness
Serious risks:
GI ulcer/bleeding
Cardiovascular thrombotic risk
Liver enzyme elevation
Renal impairment
Contraindications:
Active peptic ulcer
Severe heart disease (long-term use caution)
14. Market & Commercial Knowledge
Market type:
Massive global NSAID market
Competitors:
Ibuprofen
Naproxen
Aceclofenac
Etoricoxib (COX-2 selective)
Strength:
Strong prescription + OTC crossover (topical forms)
15. Intellectual Property (IP)
Original patents expired globally
Highly commoditized generic market
Innovation focus:
Topical delivery systems
Nano-formulations
Sustained release systems
16. Environmental & EHS Knowledge
API synthesis generates chlorinated organic waste
Wastewater treatment required
Gel manufacturing → solvent emissions control
Packaging waste (blisters, tubes)
17. Export Documentation Knowledge
Required documents:
DMF (API + finished product)
GMP certificate
COA (batch-wise)
Stability studies (ICH Q1A)
Validation reports (process + cleaning)
Bioequivalence reports
MSDS
18. Business Development Knowledge
Opportunities:
OTC pain relief segment
Hospital injectable tenders
Topical gel OTC markets (high growth)
Strategy:
Build strong dermatology + orthopedic presence
Focus on topical differentiation (gels, sprays)
Compete on price + brand trust
19. Advanced Technical Knowledge
COX inhibition is reversible and dose-dependent
High protein binding → drug interaction potential
Topical delivery bypasses systemic exposure
Fast potassium salt used for acute pain onset
NSAID class cardiovascular risk mechanism linked to prostaglandin imbalance
20. AI & Digital Knowledge (Modern Pharma)
AI applications:
Pain outcome prediction models
Topical absorption simulation
Supply chain demand forecasting
Pharmacovigilance signal detection (GI/cardiac risk patterns)
Digital pharma:
E-detailing for pain management products
Smart OTC recommendation systems
21. Sales Team Product Knowledge Checklist
Sales teams must know:
Difference between sodium vs potassium forms
GI risk counseling requirement
Short-term vs long-term use guidance
Topical advantage (fewer systemic effects)
Avoid use in high CV-risk patients (long-term)
22. Most Important Technical Documents
DMF (API & formulation)
Bioequivalence study report (oral)
Stability reports (ICH Q1A)
Photostability studies
Sterility validation (injectables)
Process Global diclofenac API Manufacturer in Durres validation reports
Cleaning validation
GMP certificate
23. Ultimate Pharma Product Mastery Summary
Diclofenac is:
A broad-spectrum NSAID with multiple delivery formats
Technically versatile:
Oral, injectable, topical
Commercially powerful:
High global demand in pain management
Manufacturing-critical:
API impurity control
Stability of injectable & gel forms